Cirius Therapeutics, Inc. — Form D

Cirius Therapeutics, Inc. of GRAND RAPIDS, MI, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-14. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Baltera BobDirectorSan Diego, CA
Daniel Estes, Ph.D.DirectorMenlo Park, CA
Dennis Fenton, Ph.D.DirectorSan Diego, CA
Nilesh Kumar, Ph.D.DirectorSan Diego, CA
Elaine SunDirectorSOUTH SAN FRANCISCO, CA
Robert Zerbe, M.D.DirectorSan Diego, CA
Baltera BobExecutive OfficerSan Diego, CA
Brian FarmerExecutive OfficerSan Diego, CA
Michael A JandernoaDirectorGrand Rapids, MI
Robert A BeardsleyExecutive OfficerGrand Rapids, MI
Robert A ZerbeDirectorGrand Rapids, MI
David A Van AndelDirectorGrand Rapids, MI
Jerry A CallahanExecutive OfficerGrand Rapids, MI
David Van AndelDirectorGrand Rapids, MI
Michael JandernoaDirectorKalamazoo, MI
Mark OlesnavageExecutive OfficerKalamazoo, MI
Robert BeardsleyExecutive OfficerSt. Louis, MO
Jerry CallahanExecutive OfficerGrand Rapids, MI
Robert ZerbeDirectorGrand Rapids, MI
Daniel EstesDirectorCarmel, IN
Nilesh KumarDirectorWatertown, MA
Robert BalteraDirectorKalamazoo, MI
Robert BalteraExecutive OfficerKalamazoo, MI
Howard DittrichExecutive OfficerKalamazoo, MI

Other filings by this issuer (5)

FiledFormOfferingSold
2025-10-08D$1.2M$800K
2024-10-15D$1.6M$1.0M
2024-08-20D$1.3M$1.3M
2018-08-30D$9.0M$9.0M
2017-04-10D$40.5M$30.0M

More